✦ LIBER ✦

Using Rituximab Plus Fludarabine and Cyclophosphamide as a Treatment for Refractory Mixed Cryoglobulinemia Associated With Lymphoma

✍ Scribed by Saadoun, D. ;Pineton de Chambrun, M. ;Hermine, O. ;Karras, A. ;Choquet, S. ;Jego, P. ;Decaux, O. ;Cacoub, P.

Book ID: 121257350
Publisher: Wiley (John Wiley & Sons)
Year: 2013
Tongue: English
Weight: 104 KB
Volume: 65
Category: Article
ISSN: 2151-464X
DOI: 10.1002/acr.21856

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Significant thrombocytopenia associated

Significant thrombocytopenia associated with the addition of rituximab to a combination of fludarabine and cyclophosphamide in the treatment of relapsed follicular lymphoma

✍ Eugen Leo; Lars Scheuer; Ingo G. H. Schmidt-Wolf; Mohammed Kerowgan; Christina S 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 140 KB

Treatment of primary mediastinal B-cell

Treatment of primary mediastinal B-cell lymphoma with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone is associated with a high rate of primary refractory disease

✍ Soumerai, Jacob D.; Hellmann, Matthew D.; Feng, Yang; Sohani, Aliyah R.; Toomey, 📂 Article 📅 2013 🏛 Informa plc 🌐 English ⚖ 403 KB

Long-term results of gemcitabine plus ox

Long-term results of gemcitabine plus oxaliplatin with and without rituximab as salvage treatment for transplant-ineligible patients with refractory/relapsing B-cell lymphoma

✍ Gaetano Corazzelli; Gaetana Capobianco; Manuela Arcamone; Pier Ferruccio Balleri 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 455 KB

Long-term results of chemoimmunotherapy

Long-term results of chemoimmunotherapy with low-dose fludarabine, cyclophosphamide and high-dose rituximab as initial treatment for patients with chronic lymphocytic leukemia

✍ Foon, K. A.; Mehta, D.; Lentzsch, S.; Kropf, P.; Marks, S.; Lenzner, D.; Pietrag 📂 Article 📅 2012 🏛 American Society of Hematology 🌐 English ⚖ 120 KB

Front-line immunochemotherapy for aggres

Front-line immunochemotherapy for aggressive non-Hodgkin lymphoma using dose-dense rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone plus granulocyte-macrophage colony stimulating factor and pegfi lgrastim as support

✍ Cabanillas, Fernando; Cotto, Maribel; Liboy, Idalia; Rivera, Ezequiel; Pavia, Or 📂 Article 📅 2012 🏛 Informa plc 🌐 English ⚖ 493 KB

5.27 Low-Dose Fludarabine and Cyclophosp

5.27 Low-Dose Fludarabine and Cyclophosphamide Combined With Rituximab Is a Safe and Effective Treatment Option for Elderly and Comorbid Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma: Preliminary Results of Project Q-lite, by the Czech CLL Study Group

✍ Lukáš Smolej; Yvona Brychtová; Martin Špaček; Michael Doubek; David Belada; Moni 📂 Article 📅 2011 🏛 Elsevier 🌐 English ⚖ 80 KB